Partnering with microbiologists to diagnose and prevent diseaseTM

March, 2022
As the COVID-19 pandemic moves into its third year, new treatment options to combat the coronavirus disease are being authorized by the U.S. Food and Drug Administration. In December, 2021, the FDA issued emergency use authorization (EUA) for two oral antiviral treatments for COVID-19, Molnupiravir and Paxlovid.(1,2)This comes at a crucial time in the pandemic... Read more »